Market Summary | Major Indices | Market Movers | Market Sectors | Mutual Funds | A-Z Stock Listings
ETF Screener | World Markets | Currencies | CEO Wealthmeter | Oil / Energy | Metals
Treasury Rates | Calculators | My Watchlist | My Portfolio
         Symbol Lookup
CELSION Add to My Watchlist (NSDQ: CLSN) 
Detailed Quote
News
Chart
SEC Filings
Profile
Historical
Options
     Celsion 2.76 -0.03 (-1.08%) 5,581
10220-L Old Columbia Road
Columbia, MD 21046 US
(410) 290-5390
(410) 290-5394 fax
www.celsion.com
CEO Michael H. Tardugno
Auditor Stegman & Company
Exchange Traded NQ
ISIN Number US15117N3052
CIK Number 749647
NAICS Code 334510
Business Summary
An innovative oncology drug development company, focused on improving treatment for those suffering with highly aggressive and difficult to treat forms of cancer.
Number of Employees 20
Share Fundamentals
Market Cap 33.43M
Shares Outstanding 12.11M
Float 9.80M
Short Interest 40.17K
Financial Strength
Revenue (TTM) $2,500,000
Earnings (TTM) -$13,859,254
Quick Ratio 3.9:1
Current Ratio 4.1:1
Total Debt/Equity 0:1
Profitability
Gross Margin -37.3%
EBITDA Margin N/A
Profit Margin N/A
Powered By: FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes.
All other data is delayed at least 20 minutes.
By accessing this page, you agree to the following terms and conditions.
Stock News provided by MarketMinute.com
Stock Analysis provided by SocialPicks Conference calls info supplied by OpenCompany
Fundamental data supplied by Mergent, Inc.
Stock quote data supplied by Telekurs